• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

    • Radiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

    • Cardiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

    • Surgery
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

At 4.2% CAGR Middle East and Turkey Hemophilia Treatment Market To Reach US$ 895.6 Million By 2027

May 24th, 2021 Coherent Market Insights Releases

SEATTLE, May 24, 2021, (MEDGADGET) — Middle East and Turkey Hemophilia Treatment Market Analysis

Desmopressin, antifibrinolytic agents, recombinant coagulation factor, and plasma-derived coagulation factor are used to treat hemophilia. Due to the favorable effects, most hemophilia patients choose factor replacement therapy as their main care. The recombinant coagulation factor segment in the Middle East and Turkey hemophilia treatment market is expected to expand as approvals and releases of recombinant coagulation factor increase. The Saudi Food and Drug Authority (SFDA) in the Kingdom of Saudi Arabia approved Swedish Orphan Biovitrum AB’s Coagulation Factor IX (Recombinant) for the treatment of hemophilia B in October 2017.

The Middle East and Turkey hemophilia treatment market is projected to reach US$ 645.1 million in 2019, with a CAGR of 4.2 percent over the forecast period (2019-2027).

For More Information, Request Sample Copy Of Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/3250

Over the forecast period, the approval and introduction of such novel products in the market are expected to fuel the growth of the Middle East and Turkey hemophilia treatment market.

During the forecast period, increasing product approvals by key players are projected to augment growth of the Middle East and Turkey hemophilia treatment market. Jivi, a new hemophilia A therapy medication with a versatile dosing regimen, was approved by the US Food and Drug Administration in August 2018. It is used to treat bleeding in adults and youth (12 years and older) who have had hemophilia A therapy previously. Furthermore, the Ministry of Food and Drug Safety approved Adynovate, a long-lasting factor VIII gene recombinant for hemophilia A cure, in February 2018, Shire Plc., the local affiliate of the multinational biotech pharmaceutical Shire.

Moreover, leading players are focusing on growth initiatives such as acquisitions, which is projected to fuel growth of the Middle East and Turkey hemophilia treatment market over the forecast period. Chatham Therapeutics, LLC, a privately owned drug research-stage biotechnology firm focused on the development of new gene therapy-mediated hemophilia drugs, was purchased by Baxter International Inc. in April 2014. Baxter bought Chatham’s developmental gene therapy technology to help with hemophilia drug production and commercialization.

Direct Purchase the Middle East and Turkey Hemophilia Treatment Market Report 2021 @ https://www.coherentmarketinsights.com/insight/buy-now/3250

Restraints

The high cost of hemophilia therapy is a significant factor that is projected to stifle growth of the Middle East and Turkey hemophilia treatment market over the projected period. Hemophilia is linked to high total expenses and places a significant financial strain on individuals and healthcare services in developing countries. Hemophilia is a debilitating illness that necessitates prolonged care, with costs differing depending on the seriousness of the disease, symptoms, and treatment schedule. Hemophilia therapy, for example, is costly, according to a cohort study undertaken by the National Center for Biotechnology Information (NCBI) in 2015. This is particularly true for patients with serious hemophilia. In all forms of hemophilia, extreme hemophilia is linked to higher annual costs, according to the report. According to a survey published by the National Center for Biotechnology Information in 2015, the annual cost of treating hemophilia A is about US$ 84,766.9 and hemophilia B is around US$ 122,877. Patients that take factor VIII inhibitors have prices that are 3.3 times more than those that do not. Therefore, the growth of the Middle East and Turkey hemophilia treatment market is projected to be hampered by the high cost of therapy over the forecast period.

Regional Analysis

Turkey is projected to experience substantial growth in the Middle East and Turkey hemophilia treatment market over the forecast period, owing to the availability of hemophilia medications and a growing patient population. ADYNOVATE is an antihemophilic recombinant factor developed by Baxalta Incorporated for Hemophilia A patients over the age of 12. It is accessible in Turkey as well as 66 other countries around the world.

Furthermore, over the forecast period, increasing funding from industry players and government organizations in providing citizens with access to hemophilia drugs is expected to accelerate market growth in Egypt. Octapharma AG donated 30.5 million units of Nuwiq, a human cell-line derived recombinant factor VIII product, to Project SHARE in November 2017 for the treatment of hemophilia A patients in developing economies such as Egypt, Bangladesh, Ethiopia, Cambodia, Myanmar, Fiji, Nepal, Kenya, and others.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/middle-east-and-turkey-hemophilia-treatment-market-2619

Competitive Landscape

Major companies contributing in the Middle East and Turkey hemophilia treatment market are Baxter International Inc., Bayer AG, Octapharma AG, Ferring B.V., Sanofi S.A., Novo Nordisk A/S, Sangamo Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Spark Therapeutics, Inc., Grifols S.A., Kedrion, Pfizer, Inc., Swedish Orphan Biovitrum AB, CSL Behring, and Biogen Inc.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By Country
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Technology Advancements
    • Historical Overview
    • Merger and Acquisition
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Middle East and Turkey Hemophilia Treatment Market, By Product Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Recombinant Coagulation Factor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Plasma Derived Coagulation Factor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Antifibrinolytic Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Desmopressin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Middle East and Turkey Hemophilia Treatment Market, By Disease Indication, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hemophilia A
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Hemophilia B
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Hemophilia C
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Middle East and Turkey Hemophilia Treatment Market, By Country, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Country, 2018 and 2027 (%)
      • Y-o-Y Growth Analysis, By Country, 2016 – 2027
      • Regional Trends
    • Turkey
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
    • Egypt
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
    • Israel
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
    • Saudi Arabia
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
    • UAE
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
    • Rest of Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

Other Related News:

MENA Biologics & Biosimilars Market, by Product Type, by Therapeutic Application, and by Region/Country – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Hemostasis Valve Market, by Type, by End Users, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

U.S. Non-oncology Biopharmaceuticals Market, by Product Type, by Drug Class, and by Disease Indication and Others (Cardiac Diseases and Others)) – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2026

Hemophilia Gene Therapy Market – by Hemophilia Type and by Region – Size, Share, Trends, and Forecast to 2026

Hemophilia Treatment Market, by Product Type, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Advanced Therapy Medicinal Products Market – By Product, By Diseases – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2021-2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email